CRISPR Therapeutics AG
CRSP | NASDAQ
$50.76
-$0.66 (-1.28%)
Nov 2, 2026, 10:46 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.39M | 4.1M | 3.51M | 37.65M | 37.36M | 36.98M | 36.62M | 201.62M | 201.02M | 270.5M | 370M | 170.01M | 170.1M | 100.26M | 436K | 13.33M | 13.56M | 913.61M | 913.63M | 901.1M | 900.92M | 764K |
Cost of Revenue | 218.88M | 224.06M | 231.32M | 171.96M | 123.22M | 130.44M | 124.73M | 144.73M | 152.2M | 139.86M | 130.25M | 117.07M | 132.51M | 121.8M | 110.25M | 238.35M | 221.95M | 214.97M | 204.27M | 151.72M | 200.26M | 232.7M |
Gross Profit | -205.49M | -219.96M | -227.81M | -134.31M | -85.86M | -93.45M | -88.11M | 56.9M | 48.82M | 130.65M | 239.75M | 52.93M | 37.59M | -21.54M | -109.81M | -225.02M | -208.39M | 698.63M | 709.36M | 749.38M | 700.66M | -231.93M |
Operating Income | -531.87M | -550.14M | -568.32M | -478.14M | -456.21M | -474.4M | -466.57M | -332.39M | -354.68M | -298.64M | -222.54M | -423.66M | -473.64M | -561.68M | -673.16M | -687.32M | -633.78M | 312.1M | 373.53M | 411.47M | 447.92M | -395.39M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -448.11M | -565.17M | -577.97M | -484.58M | -463.82M | -381.69M | -362.67M | -236.47M | -263.15M | -214.84M | -150.72M | -360.35M | -423.74M | -526.64M | -650.5M | -669.44M | -622.07M | 321.02M | 384.04M | 416.14M | 451.65M | -391M |
Net Income | -451.14M | -568.53M | -581.6M | -488.3M | -467.8M | -385.66M | -366.25M | -239.59M | -265.8M | -217.14M | -153.61M | -353.53M | -415.93M | -524.02M | -650.18M | -680.85M | -633.45M | 311.61M | 377.66M | 411.87M | 446.58M | -392.3M |
Selling & General & Admin | 67.97M | 71.43M | 73.54M | 73.27M | 73.76M | 74.32M | 72.98M | 71.33M | 72.2M | 71.76M | 76.16M | 80.85M | 89.56M | 96.8M | 102.46M | 104.97M | 101.68M | 104.21M | 100.71M | 102.8M | 100.63M | 93.18M |
Research & Development | 270.29M | 270.64M | 274.55M | 278.84M | 297.29M | 307.32M | 306.17M | 319.16M | 332.5M | 358.74M | 387.33M | 395.74M | 421.67M | 443.34M | 461.65M | 461.19M | 428.06M | 387.17M | 339.55M | 318.82M | 306.33M | 283.37M |
Other Expenses | -11.88M | -11.88M | -7.58M | -8.27M | -691K | -691K | -691K | -1.21M | -1.21M | -1.21M | -1.21M | n/a | n/a | n/a | -762K | -103.86M | -104.35M | -104.85M | -104.43M | -83.7M | -154.21M | -213.09M |
Operating Expenses | 326.38M | 330.19M | 340.51M | 343.83M | 370.36M | 380.95M | 378.46M | 389.29M | 403.5M | 429.29M | 462.29M | 476.6M | 511.23M | 540.14M | 563.35M | 462.3M | 425.39M | 386.54M | 335.83M | 337.92M | 252.74M | 163.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 545.26M | 554.24M | 571.83M | 515.79M | 493.57M | 511.39M | 503.19M | 534.02M | 555.7M | 569.14M | 592.54M | 593.67M | 643.74M | 661.93M | 673.6M | 700.65M | 647.34M | 601.51M | 540.1M | 489.64M | 453.01M | 396.16M |
Income Tax Expense | 3.03M | 3.36M | 3.63M | 3.72M | 3.98M | 3.97M | 3.59M | 3.12M | 2.66M | 2.29M | 2.89M | -6.82M | -7.81M | -2.61M | -325K | 11.4M | 11.38M | 9.41M | 6.38M | 4.27M | 5.06M | 1.3M |
Shares Outstanding (Basic) | 96.51M | 96.05M | 89.93M | 91.31M | 87.07M | 85.94M | 85.46M | 85.24M | 84.92M | 81.79M | 79.69M | 79.41M | 79.09M | 78.68M | 78.34M | 77.92M | 77.43M | 77.1M | 76.65M | 76.14M | 75.83M | 74.94M |
Shares Outstanding (Diluted) | 96.51M | 96.05M | 89.93M | 91.31M | 87.07M | 85.94M | 85.46M | 85.24M | 84.92M | 81.79M | 81.32M | 79.41M | 79.09M | 78.68M | 78.34M | 78.02M | 77.51M | 77.1M | 76.65M | 76.29M | 80.45M | 75.01M |
EPS (Basic) | -4.76 | -6.22 | -6.52 | -5.59 | -5.43 | -4.52 | -4.37 | -2.81 | -3.21 | -2.70 | -1.94 | -4.47 | -5.30 | -6.72 | -8.37 | -8.80 | -8.23 | 4.18 | 4.99 | 5.30 | 5.65 | -5.66 |
EPS (Diluted) | -4.76 | -6.22 | -6.52 | -5.59 | -5.43 | -4.52 | -4.37 | -2.83 | -3.23 | -2.72 | -1.96 | -4.47 | -5.30 | -6.72 | -8.37 | -8.80 | -8.23 | 3.61 | 4.42 | 4.73 | 5.08 | -5.66 |
EBITDA | -454M | -546.16M | -558.54M | -465.97M | -444.9M | -362.52M | -343.41M | -217.16M | -243.65M | -195.23M | -130.89M | -339.57M | -402.86M | -503.45M | -626.33M | -644.86M | -597.18M | 342.29M | 400.03M | 427.57M | 459.93M | -385.58M |
EBIT | -472.71M | -565.17M | -577.97M | -484.58M | -463.82M | -381.69M | -362.67M | -236.47M | -263.15M | -214.84M | -150.72M | -360.35M | -423.74M | -526.64M | -650.5M | -669.44M | -622.07M | 321.02M | 382.08M | 413.32M | 448.67M | -395.39M |
Depreciation & Amortization | 18.71M | 19.01M | 19.43M | 18.61M | 18.92M | 19.16M | 19.26M | 19.32M | 19.5M | 19.62M | 19.84M | 20.78M | 20.88M | 23.18M | 24.17M | 24.59M | 24.89M | 21.28M | 17.95M | 14.26M | 11.27M | 9.81M |
Add to Watchlist
Select watchlists to add or remove CRSP